|
1
|
McMahon GM, Hwang SJ and Fox CS: Residual
lifetime risk of chronic kidney disease. Nephrol Dial Transplant.
pii: gfw253. 2016. View Article : Google Scholar
|
|
2
|
Stenvinkel P: Chronic kidney disease: A
public health priority and harbinger of premature cardiovascular
disease. J Intern Med. 268:456–467. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stojceva-Taneva O, Otovic NE and Taneva B:
Prevalence of diabetes mellitus in patients with chronic kidney
disease. Open Access Maced J Med Sci. 4:79–82. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Foley RN, Parfrey PS and Sarnak MJ:
Clinical epidemiology of cardiovascular disease in chronic renal
disease. Am J Kidney Dis. 32(5 Suppl 3): S112–S119. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Matsui M, Takeda Y, Uemura S, Matsumoto T,
Seno A, Onoue K, Tsushima H, Morimoto K, Soeda T, Okayama S, et al:
Suppressed soluble Fms-like tyrosine kinase-1 production aggravates
atherosclerosis in chronic kidney disease. Kidney Int. 85:393–403.
2014. View Article : Google Scholar
|
|
6
|
Go AS, Chertow GM, Fan D, McCulloch CE and
Hsu CY: Chronic kidney disease and the risks of death,
cardiovascular events, and hospitalization. N Engl J Med.
351:1296–1305. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gluba-Brzózka A, Michalska-Kasiczak M,
Franczyk B, Nocuń M, Toth P, Banach M and Rysz J: Markers of
increased atherosclerotic risk in patients with chronic kidney
disease: A preliminary study. Lipids Health Dis. 15:222016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roberts JK and McCullough PA: The
management of acute coronary syndromes in patients with chronic
kidney disease. Adv Chronic Kidney Dis. 21:472–479. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Di Angelantonio E, Chowdhury R, Sarwar N,
Aspelund T, Danesh J and Gudnason V: Chronic kidney disease and
risk of major cardiovascular disease and non-vascular mortality:
Prospective population based cohort study. BMJ. 341:c49862010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hage FG, Venkataraman R, Zoghbi GJ, Perry
GJ, DeMattos AM and Iskandrian AE: The scope of coronary heart
disease in patients with chronic kidney disease. J Am Coll Cardiol.
53:2129–2140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Martinez AW, Recht NS, Hostetter TH and
Meyer TW: Removal of P-cresol sulfate by hemodialysis. J Am Soc
Nephrol. 16:3430–3436. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lekawanvijit S, Adrahtas A, Kelly DJ,
Kompa AR, Wang BH and Krum H: Does indoxyl sulfate, a uraemic
toxin, have direct effects on cardiac fibroblasts and myocytes? Eur
Heart J. 31:1771–1779. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu IW, Hsu KH, Lee CC, Sun CY, Hsu HJ,
Tsai CJ, Tzen CY, Wang YC, Lin CY and Wu MS: p-Cresyl sulphate and
indoxyl sulphate predict progression of chronic kidney disease.
Nephrol Dial Transplant. 26:938–947. 2011. View Article : Google Scholar :
|
|
14
|
Liabeuf S, Barreto DV, Barreto FC, Meert
N, Glorieux G, Schepers E, Temmar M, Choukroun G, Vanholder R and
Massy ZA; European Uraemic Toxin Work Group (EUTox): Free
p-cresylsulphate is a predictor of mortality in patients at
different stages of chronic kidney disease. Nephrol Dial
Transplant. 25:1183–1191. 2010. View Article : Google Scholar
|
|
15
|
Gansevoort RT, Correa-Rotter R, Hemmelgarn
BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K and Wen CP:
Chronic kidney disease and cardiovascular risk: Epidemiology,
mechanisms, and prevention. Lancet. 382:339–352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kaluski E, Waller A, Patel A, Gerula C,
Maher J, Haider B and Klapholz M: Clinical applicability of
coronary atherosclerotic lesion characterization. Minerva
Cardioangiol. 59:255–270. 2011.PubMed/NCBI
|
|
17
|
Ruggeri ZM: Platelets in atherothrombosis.
Nat Med. 8:1227–1234. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakamura K, Sasaki T, Cheng XW, Iguchi A,
Sato K and Kuzuya M: Statin prevents plaque disruption in
apoE-knockout mouse model through pleiotropic effect on acute
inflammation. Atherosclerosis. 206:355–361. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Werner N, Nickenig G and Laufs U:
Pleiotropic effects of HMG-CoA reductase inhibitors. Basic Res
Cardiol. 97:105–116. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feigenbaum J and Neuberg CA: Simplified
method for the preparation of aromatic sulfuric acid esters. J Am
Chem Soc. 63:3529–3530. 1941. View Article : Google Scholar
|
|
21
|
Han H, Zhu J, Zhu Z, Ni J, Du R, Dai Y,
Chen Y, Wu Z, Lu L and Zhang R: p-Cresyl sulfate aggravates cardiac
dysfunction associated with chronic kidney disease by enhancing
apoptosis of cardiomyocytes. J Am Heart Assoc. 4:e0018522015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vanholder R, Schepers E, Pletinck A,
Nagler EV and Glorieux G: The uremic toxicity of indoxyl sulfate
and p-cresyl sulfate: A systematic review. J Am Soc Nephrol.
25:1897–1907. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nie P, Li D, Hu L, Jin S, Yu Y, Cai Z,
Shao Q, Shen J, Yi J, Xiao H, et al: Atorvastatin improves plaque
stability in ApoE-knockout mice by regulating chemokines and
chemokine receptors. PLoS One. 9:e970092014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meng X, Zhang K, Li J, Dong M, Yang J, An
G, Qin W, Gao F, Zhang C and Zhang Y: Statins induce the
accumulation of regulatory T cells in atherosclerotic plaque. Mol
Med. 18:598–605. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang XQ, Nigro P, World C, Fujiwara K, Yan
C and Berk BC: Thioredoxin interacting protein promotes endothelial
cell inflammation in response to disturbed flow by increasing
leukocyte adhesion and repressing Kruppel-like factor 2. Circ Res.
110:560–568. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang XQ, Wan HQ, Wei XJ, Zhang Y and Qu P:
CLI-095 decreases atherosclerosis by modulating foam cell formation
in apolipoprotein E-deficient mice. Mol Med Rep. 14:49–56.
2016.PubMed/NCBI
|
|
27
|
Dong M, Yang X, Lim S, Cao Z, Honek J, Lu
H, Zhang C, Seki T, Hosaka K, Wahlberg E, et al: Cold exposure
promotes atherosclerotic plaque growth and instability via
UCP1-dependent lipolysis. Cell Metab. 18:118–129. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Akhmedov A, Rozenberg I, Paneni F, Camici
GG, Shi Y, Doerries C, Sledzinska A, Mocharla P, Breitenstein A,
Lohmann C, et al: Endothelial overexpression of LOX-1 increases
plaque formation and promotes atherosclerosis in vivo. Eur Heart J.
35:2839–2848. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ouedraogo R, Gong Y, Berzins B, Wu X,
Mahadev K, Hough K, Chan L, Goldstein BJ and Scalia R: Adiponectin
deficiency increases leukocyte-endothelium interactions via
upregulation of endothelial cell adhesion molecules in vivo. J Clin
Invest. 117:1718–1726. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou M, Ma C, Liu W, Liu H, Wang N, Kang Q
and Li P: Valsartan promoting atherosclerotic plaque stabilization
by upregulating renalase: A potential-related gene of
atherosclerosis. J Cardiovasc Pharmacol Ther. 20:509–519. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ross R: Atherosclerosis-an inflammatory
disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Haft JI: Multiple atherosclerotic plaque
rupture in acute coronary syndrome. Circulation. 107:e65–e66;
author reply e65–e66. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bergström G, Fagerberg B, Sallsten G,
Lundh T and Barregard L: Is cadmium exposure associated with the
burden, vulnerability and rupture of human atherosclerotic plaques?
PLoS One. 10:e01212402015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang K, Meng X, Kong J, Liu FF, Yang JM,
Gao F, Zhang Y and Zhang C: Simvastatin increases
Prolyl-4-Hydroxylase α1 expression in atherosclerotic plaque and
ox-LDL-stimulated human aortic smooth muscle cells via p38 MAPK and
ERK1/2 signaling. J Mol Cell Cardiol. 65:43–50. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Erbel C, Wolf A, Lasitschka F, Linden F,
Domschke G, Akhavanpoor M, Doesch AO, Katus HA and Gleissner CA:
Prevalence of M4 macrophages within human coronary atherosclerotic
plaques is associated with features of plaque instability. Int J
Cardiol. 186:219–225. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Molina-Sánchez P, Chèvre R, Rius C, Fuster
JJ and Andrés V: Loss of p27 phosphorylation at Ser10 accelerates
early atherogenesis by promoting leukocyte recruitment via
RhoA/ROCK. J Mol Cell Cardiol. 84:84–94. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hartwig H, Silvestre Roig C, Daemen M,
Lutgens E and Soehnlein O: Neutrophils in atherosclerosis. A brief
overview. Hamostaseologie. 35:121–127. 2015. View Article : Google Scholar
|
|
38
|
Inoue M, Ishida T, Yasuda T, Toh R, Hara
T, Cangara HM, Rikitake Y, Taira K, Sun L, Kundu RK, et al:
Endothelial cell-selective adhesion molecule modulates
atherosclerosis through plaque angiogenesis and
monocyte-endothelial interaction. Microvasc Res. 80:179–187. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fu C, He J, Li C, Shyy JY and Zhu Y:
Cholesterol increases adhesion of monocytes to endothelium by
moving adhesion molecules out of caveolae. Biochim Biophys Acta.
1801:702–710. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Strippoli GF, Navaneethan SD, Johnson DW,
Perkovic V, Pellegrini F, Nicolucci A and Craig JC: Effects of
statins in patients with chronic kidney disease: Meta-analysis and
meta-regression of randomised controlled trials. BMJ. 336:645–651.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rysz J, Gluba-Brzózka A, Banach M and
Więcek A: Should we use statins in all patients with chronic kidney
disease without dialysis therapy? The current state of knowledge.
Int Urol Nephrol. 47:805–813. 2015. View Article : Google Scholar : PubMed/NCBI
|
